Click here for Analysts' Upgrades, Downgrades.
Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
STOCK COMMENTS / EPS CHANGES
estimates, target upped at Goldman. ACM estimates were boosted through 2013. Company is realizing higher margins. Neutral rating and new $30 price target.
estimates, target increased at Goldman. AZO estimates were raised through 2013. Company is seeing higher sales and is buying back stock. Sell rating and new $246 price target.
numbers raised at Barclays. Shares of CAR now seen reaching $18. Estimates also increased, as demand continues to recover. Overweight rating.
numbers upped at Credit Suisse. CCE estimates were boosted through 2012. Company is seeing better sales and facing lower debt costs. Outperform rating and new $31 price target.
estimates, target upped at BofA/Merrill. CSX estimates were boosted through 2012. Company is carrying strong operating momentum into the new year. Buy rating and new $72 price target.
numbers raised at Goldman. Shares of DIS now seen reaching $43. Estimates also increased, as the company is seeing higher parks revenue. Buy rating.
numbers boosted at UBS. Shares of ESL now seen reaching $60. Estimates also upped, as sales growth is driving higher margins. Neutral rating.
estimates, target increased at Barclays. HAL estimates were raised through 2011. Company should continue to post growth in North America. Overweight rating and new $53 price target.
estimates cut at Credit Suisse through 2012. Company is seeing weaker group insurance underwriting and compressed universal life spreads. Neutral rating.
estimates, target boosted at FBR. Shares of MSCC now seen reaching $30. Estimates also upped, to match the company's new guidance. Outperform rating.
numbers boosted at Goldman. Shares of TTEK now seen reaching $25. Estimates also upped, as the company is seeing lower amortization costs. Neutral rating.
estimates, target increased at UBS. URS estimates were raised through 2011. Company is growing its backlog and boosted guidance. Neutral rating and new $44 price target.
estimates, target raised at UBS. Shares of VIA.B now seen reaching $44. Estimates also increased, given better U.S. advertising growth. Buy rating.
This article was written by a staff member of TheStreet.